Is Teladoc a big company?

Teladoc Health is the largest telemedicine provider, with $1.09 billion in revenue and over 1,800 employees.

Who is Teladoc biggest competitor?

Amwell (NYSE: AMWL), formerly known as American Well, is a telemedicine company founded in 2006 and went public in 2020. It is currently the biggest competitor to Teladoc in the telehealth space and has experienced significant growth in recent years.

How large is Teladoc?

Currently headquartered in Purchase, New York, as of 2019, the company was active in 130 countries and had around 27 million members. David Sides was appointed COO in 2019. In 2019, the company had revenues of $533 million and 4.1 million total visits.

Does Teladoc make a profit?

The telehealth giant isn't yet profitable and reported a loss of $84.3 million in the third quarter of 2021, deeper than its year-prior loss of $36 million. Shares of Teladoc stock fell 6.2% on Monday as of 10:47 a.m. in New York.

Is Teladoc a good company?

The employee experience below at Teladoc Health (formerly Livongo), compared to a typical company. 84% of employees at Teladoc Health (formerly Livongo) say it is a great place to work compared to 57% of employees at a typical U.S.-based company. Source: Great Place to Work® 2021 Global Employee Engagement Study.

Teladoc Health CEO: We're defining a new category of virtual whole-person care

Why is Teladoc doing so poorly?

Teladoc stock faces turbulence with shrinking Q4 losses but modest 2022 guidance. Teladoc stock fell in after-hours trading Tuesday after the telehealth giant posted fourth-quarter earnings, despite results exceeding Wall Street's expectations on profit and revenue.

Why is Teladoc losing so much money?

The loss in the first quarter was mainly driven by a noncash goodwill impairment charge of $6.6 billion, which is often recorded on the income statement after a company acknowledges that an asset has lost value or become completely worthless.

Does Teladoc have a future?

Teladoc's total visits in 2021 increased by 38% YOY to 15.4 million. The company's average revenue per U.S. member has also been increasing consistently, going from $0.80 in the first quarter of 2020 to $2.49 in the fourth quarter of 2021.

Is Teladoc going to rise?

While Teladoc stock has been on a steady decline over the past year, the company's revenue growth is increasing. In the third quarter of 2021, the company reported year-over-year revenue growth of 81%. Of course, Teladoc's continued revenue growth places it in a favorable position moving forward.

Who are Teladoc competitors?

Teladoc Health's top competitors include naviHealth, Lash Group, Amwell, 98point6, MDLIVE, Providence Service Corporation and Sharecare. Teladoc Health is a telehealth company that uses telephone and video conferencing technology to provide on-demand remote medical care via mobile devices, the internet, and video.

How many people work at Teladoc?

Teladoc Health total number of employees in 2021 was 5,100, a 15.91% increase from 2020. Teladoc Health total number of employees in 2020 was 4,400, a 83.33% increase from 2019. Teladoc Health total number of employees in 2019 was 2,400, a 20% increase from 2018.

Is Teladoc owned by Aetna?

Teladoc and Teladoc physicians are independent contractors and are not agents of Aetna. For a complete description of the limitations of Teladoc services, visit Teladoc.com/Aetna. Teladoc, Teladoc Health and the Teladoc Health logo are registered trademarks or trademarks of Teladoc Health, Inc.

What companies does Teladoc own?

Which telemedicine company is best?

Which telemedicine company pays the most?

Is Teladoc overvalued?

Valuation metrics show that Teladoc Health, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of TDOC, demonstrate its potential to underperform the market.

Is Teladoc undervalued?

The revenue per member was reported $2.32 in 2021, up from $1.12 in 2020. I believe Teladoc's stock price is undervalued based on relative valuation indicators. The stock's price-to-sales ratio hit below 4 in mid-March (lowest since 2016) and is trading at 5.33, while the price-to-book ratio is at 0.69.

Is Teladoc an acquisition target?

As a reader, you need to bear in mind that Teladoc is an acquisition vehicle; we thus need to consider that its "struggle towards profitability" has been down to transitory costs rather than a flawed business model.

Is Teladoc stock a good investment?

Teladoc has a first-mover advantage in this field and is poised for a rosy future. Beyond that, the telehealth company boasts excellent financial performance. In 2021, Teladoc's total revenue jumped 86% year over year (YOY) to reach $2 billion. Visits on its platform surged 38% to reach 15.4 million.

What did Teladoc pay for Livongo?

Teladoc, the largest virtual care company in the U.S., bought Livongo for $18.5 billion in cash and stock late 2020 in the biggest digital health deal to date. However, the merger has struggled, resulting in the large goodwill impairment charge for the Purchase, New York-based vendor.

Does Teladoc have its own doctors?

All the doctors in Teladoc's national network are U.S. board-certified family practitioners, primary care physicians, pediatricians and internists who use Electronic Health Records to diagnose, treat and write prescriptions when necessary. When accessing Teladoc, you'll be connected to a doctor in your state.

Is Teladoc a healthcare provider?

The Teladoc Health Medical Group is a world-class practice with a passion for taking care of people and a devotion to clinical excellence. From family medicine to mental health to expert medical advice, our care providers help millions of people around the world by delivering high-quality care in a virtual setting.